Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015Oct 28, 2019HiFiBiO Therapeutics Establishes World-Class Scientific Advisory BoardAug 28, 2019HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune DisordersJun 3, 2019HiFiBiO Therapeutics and Leading Academic Institutions Demonstrate Breakthrough Single-Cell Approach for Novel Biomarker Discovery to Combat CancerFeb 13, 2019Victa Biotherapeutics Appoints Donald W. Kufe to Board of DirectorsDec 10, 2018HiFiBiO Therapeutics and Vikas Sukhatme Join Forces to Discover and Develop Novel Antibody Treatments for Cancer< 1 … 11 12 13 14 15 … 17 >
